Pictet Asset Management
WST icon

Pictet Asset Management’s West Pharmaceutical WST Stock Holding History

Pictet Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Sell
38,205
-5,985
-14% -$1.83M 0.01% 619
2026
Q1 		$11.1M Sell
44,190
-107,807
-71% -$26.8M 0.01% 633
2025
Q4 		$41.8M Sell
151,997
-38,116
-20% -$10.4M 0.04% 357
2025
Q3 		$49.9M Sell
190,113
-20,389
-10% -$4.96M 0.05% 327
2025
Q2 		$46.1M Buy
210,502
+76,151
+57% +$16.3M 0.05% 328
2025
Q1 		$30.1M Buy
134,351
+16,880
+14% +$4.65M 0.03% 397
2024
Q4 		$38.5M Sell
117,471
-17,574
-13% -$5.53M 0.04% 351
2024
Q3 		$40.5M Sell
135,045
-2,854
-2% -$874K 0.04% 335
2024
Q2 		$45.4M Buy
137,899
+35,985
+35% +$12.7M 0.05% 300
2024
Q1 		$40.3M Buy
101,914
+62,452
+158% +$23.1M 0.04% 350
2023
Q4 		$13.9M Sell
39,462
-755
-2% -$267K 0.02% 564
2023
Q3 		$15.1M Buy
+40,217
New +$15.6M 0.02% 533

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pictet Asset Management's WST Position: Q2 2026 in Review

Pictet Asset Management reduced its West Pharmaceutical (WST) stake by 14% in Q2 2026, selling an estimated $1.83M and leaving 38,205 shares worth $13.7M. The position accounts for 0.01% of the portfolio, ranked #619.

Pictet Asset Management first reported a position in WST in Q3 2023 and has held it in 12 quarters since. The position peaked at $49.9M in Q3 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Pictet Asset Management held 38,205 shares of West Pharmaceutical worth $13.7M as of Q2 2026.
  • Pictet Asset Management sold 5,985 West Pharmaceutical shares in Q2 2026, an estimated $1.83M.
  • West Pharmaceutical made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #619 holding.
  • Pictet Asset Management first reported a position in West Pharmaceutical in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's West Pharmaceutical position peaked at $49.9M in Q3 2025.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.